Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Aidapak Services, LLC is recalling Tizanidine HCl tablets that may be mislabeled as Pyridoxine HCl. The error could lead to patients taking the wrong medication.
Aidapak Services is recalling Pantoprazole Sodium 20 mg tablets because they may be mislabeled as Dronedarone HCL 400 mg.
Specialty Medicine Compounding Pharmacy is recalling Cyclopentolate HCL ophthalmic products because sterility cannot be assured after a related product was found non-sterile.
Aidapak Services, LLC is recalling bupropion HCl ER tablets that may be mislabeled as mesalamine CR capsules due to a labeling mixup.
Specialty Medicine Compounding Pharmacy is recalling Papav/Phentol/PG E1 injectable products because sterility cannot be assured after a related product was found non-sterile.
Aidapak Services is recalling Mesalamine CR capsules that may be mislabeled as Aspirin EC tablets due to a labeling error.
Specialty Medicine Compounding Pharmacy is recalling Hydroxyprogesterone 17alpha-PF 250 mg/mL injectable because sterility cannot be assured after a related product was found non-sterile.
Aidapak Services is recalling Quetiapine Fumarate tablets that may be mislabeled as Simvastatin. The FDA classifies this as a Class II recall.
Specialty Medicine Compounding Pharmacy is recalling Calcium Chloride PF 500 mg/mL prefilled syringes because sterility cannot be assured after a related product was found non-sterile.
Aidapak Services, LLC is recalling 1 mg melatonin tablets that may be mislabeled as quetiapine fumarate or docusate sodium.
Specialty Medicine Compounding Pharmacy is recalling all unexpired sterile compounded human and veterinary products because sterility cannot be assured due to shared compounding practices with a non-sterile product.
Specialty Medicine Compounding Pharmacy is recalling Hydroxocobalamin/Thiamine Injectable due to lack of assurance of sterility. The product was distributed to healthcare providers in Michigan.
Specialty Medicine Compounding Pharmacy is recalling Fluorouracil PF 50 mg/mL injectable because sterility cannot be assured after another product was found non-sterile in the same environment.
Aidapak Services is recalling Finasteride 5 mg tablets that may be mislabeled as Digoxin or Phytonadione. The error poses a risk of incorrect medication administration.
Specialty Medicine Compounding Pharmacy is recalling Tropicamide 1% Ophthalmic Solution because sterility cannot be assured after a related product was found non-sterile.
Aidapak Services, LLC is recalling calcium citrate tablets that may be mislabeled as trimethobenzamide HCL capsules.
Aidapak Services, LLC is recalling Docusate Sodium capsules because they may be mislabeled as other medications. The affected products were distributed in four western states.
Aidapak Services, LLC is recalling TACROLIMUS Capsules, 1 mg, because they may be mislabeled as LEVOTHYROXINE SODIUM Tablets, 125 mcg.
Aidapak Services, LLC is recalling FIDAXOMICIN 200 mg tablets that may be mislabeled as BENAZEPRIL HCL 40 mg. The error affects repacked drugs distributed in four western states.
Aidapak Services is recalling 400 mg ibuprofen tablets that may be mislabeled as 325 mg aspirin. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling Vitamin B Complex with C/Folic Acid tablets because they may be mislabeled as other prescription or over-the-counter medications.
Lupin Pharmaceuticals is recalling Quinapril 10 mg tablets because stability testing revealed an unknown impurity above specification limits.
Aidapak Services, LLC is recalling guaiFENesin ER tablets because they may be mislabeled as fenofibrate or glyburide. The error poses a risk of patients taking the wrong medication.
Aidapak Services is recalling methylprednisolone tablets that may be mislabeled as levothyroxine sodium due to a labeling mixup.
Aidapak Services is recalling Zolpidem Tartrate tablets that may be mislabeled as Temazepam capsules due to a label mixup.